avoir une population très âgée et particulièrement fragile (patients hospitalisés en gériatrie) Les raisons d'hospitalisation étaient principalement les AVC, les décompensations cardiaques, pneumopathies, chutes et les troubles cognitifs majeurs ,
Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study, Heart, vol.86, issue.5, pp.516-537, 2001. ,
DOI : 10.1136/heart.86.5.516
Prevalence of Diagnosed Atrial Fibrillation in Adults, JAMA, vol.285, issue.18, pp.2370-2375 ,
DOI : 10.1001/jama.285.18.2370
Epidemiology of atrial fibrillation: European perspective, Clinical Epidemiology, vol.6, pp.213-233, 2014. ,
DOI : 10.2147/CLEP.S47385
Guidelines for the management of atrial fibrillation : the task force for the management of atrial fibrillation of the European society of cardiology (ESC), Eur Heart J, vol.31, pp.2369-429, 2010. ,
Consensus d'experts de la Société française de gériatrie et gérontologie et de la Société française de cardiologie, sur la prise en charge de la fibrillation atriale du sujet âgé, Geriatr Psychol Neuropsychiatr Vieil. 2013, vol.11, issue.2, pp.117-160 ,
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study, European Heart Journal, vol.27, issue.8, pp.949-53, 2006. ,
DOI : 10.1093/eurheartj/ehi825
Epidemiology of atrial fibrillation: European perspective, Clinical Epidemiology, vol.6, pp.213-233, 2014. ,
DOI : 10.2147/CLEP.S47385
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications, Archives of Internal Medicine, vol.155, issue.5, pp.469-73, 1995. ,
DOI : 10.1001/archinte.155.5.469
Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data, Archives of Cardiovascular Diseases, vol.104, issue.2, pp.115-139, 2011. ,
DOI : 10.1016/j.acvd.2010.11.012
Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment: Results of a Prospective Collaborative Study on Elderly Patients Followed by Italian Centres for Anticoagulation, Circulation, vol.124, issue.7, pp.824-833, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.110.007864
The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation, Annals of Internal Medicine, vol.151, issue.5, pp.297-305, 2009. ,
DOI : 10.7326/0003-4819-151-5-200909010-00003
Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study, Circulation, vol.125, issue.19, pp.2298-307, 2012. ,
DOI : 10.1161/CIRCULATIONAHA.111.055079
Antithrombotic therapy in very elderly patients with atrial fibrillation: is it enough to assess thromboembolic risk? Clin Interv Aging, pp.157-62, 2010. ,
Cognitive Impairment Associated With Atrial Fibrillation, Annals of Internal Medicine, vol.158, issue.5_Part_1, pp.338-384, 2013. ,
DOI : 10.7326/0003-4819-158-5-201303050-00007
Risk of thromboembolic events in atrial fibrillation with chronic kidney disease. Stroke, pp.157-63, 2015. ,
Impact of Atrial Fibrillation on the Risk of Death : The Framingham Heart Study, Circulation, vol.98, issue.10, pp.946-52, 1998. ,
DOI : 10.1161/01.CIR.98.10.946
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study, The American Journal of Medicine, vol.113, issue.5, pp.359-64, 2002. ,
DOI : 10.1016/S0002-9343(02)01236-6
Impact of Atrial Fibrillation on Mortality, Stroke, and Medical Costs, Archives of Internal Medicine, vol.158, issue.3, pp.229-263, 1998. ,
DOI : 10.1001/archinte.158.3.229
Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: a nationwide database study, Open Heart, vol.2, issue.1, p.290, 2015. ,
DOI : 10.1136/openhrt-2015-000290
Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies, BMJ, vol.532, p.7013, 2016. ,
DOI : 10.1136/bmj.h7013
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation, European Heart Journal, vol.29, issue.9, pp.1181-1190, 2008. ,
DOI : 10.1093/eurheartj/ehn139
Cognitive Impairment Associated With Atrial Fibrillation, Annals of Internal Medicine, vol.158, issue.5_Part_1, pp.338-384, 2013. ,
DOI : 10.7326/0003-4819-158-5-201303050-00007
Indication des anticoagulants dans la fibrillation auriculaire au regard du risque cérébrovasculaire. Geriatr Psychol Neuropsychiatr Vieil, pp.23-33, 2013. ,
Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke: Results From a Population-Based Study, Stroke, vol.36, issue.6, pp.1115-1124, 2005. ,
DOI : 10.1161/01.STR.0000166053.83476.4a
High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke, Stroke, vol.45, issue.9, pp.2599-605, 2014. ,
DOI : 10.1161/STROKEAHA.114.006070
High incidence of atrial fibrillation or flutter in stroke patients who have the clinical risk factors for stroke, J Atrial Fibrill, vol.6, pp.114-119, 2013. ,
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke, vol.22, issue.8, pp.983-991, 1991. ,
DOI : 10.1161/01.STR.22.8.983
11-034-A-10, p.31, 2011. ,
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke, vol.22, issue.8, pp.983-991, 1991. ,
DOI : 10.1161/01.STR.22.8.983
Poor Outcome After First-Ever Stroke: Predictors for Death, Dependency, and Recurrent Stroke Within the First Year, Stroke, vol.34, issue.1, pp.122-128, 2003. ,
DOI : 10.1161/01.STR.0000047852.05842.3C
URL : http://stroke.ahajournals.org/content/strokeaha/34/1/122.full.pdf
Stroke Severity in Atrial Fibrillation: The Framingham Study, Stroke, vol.27, issue.10, pp.1760-1764, 1996. ,
DOI : 10.1161/01.STR.27.10.1760
Time Trends of Ischemic Stroke Incidence and Mortality in Patients Diagnosed With First Atrial Fibrillation in 1980 to 2000: Report of a Community-Based Study, Stroke, vol.36, issue.11, pp.2362-2368, 2005. ,
DOI : 10.1161/01.STR.0000185927.63746.23
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation, Annals of Internal Medicine, vol.146, issue.12, pp.857-67, 2007. ,
DOI : 10.7326/0003-4819-146-12-200706190-00007
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial, The Lancet, vol.370, issue.9586, pp.493-503, 2007. ,
DOI : 10.1016/S0140-6736(07)61233-1
A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO), Age and Ageing, vol.36, issue.2, pp.151-157, 2007. ,
DOI : 10.1093/ageing/afl129
Efficacy and Safety of Oral Anticoagulants Versus Aspirin for Patients With Atrial Fibrillation, Medicine, vol.94, issue.4, p.409 ,
DOI : 10.1097/MD.0000000000000409
Guidelines for the management of atrial fibrillation : the Task Force for the management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur Heart J, vol.31, pp.2369-2429, 2010. ,
L???anticoagulation dans la fibrillation atriale du sujet ??g????: point de vue du g??riatre avec un focus sur les anticoagulants oraux directs, La Revue de M??decine Interne, vol.36, issue.1, pp.22-30 ,
DOI : 10.1016/j.revmed.2014.08.005
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients, Journal of Thrombosis and Haemostasis, vol.1, issue.4, pp.692-696, 2005. ,
DOI : 10.1111/j.1538-7836.2005.01204.x
Clinical practice. Care of patients receiving long-term anticoagulant therapy ,
Haemorrhagic Complications of Vitamin K Antagonists in the Elderly, Drugs & Aging, vol.35, issue.10, pp.13-25, 2006. ,
DOI : 10.7326/0003-4819-137-4-200208200-00009
Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance, Thérapie. févr, vol.54, issue.1, pp.21-27, 1999. ,
Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres, 1036. 46 EMIR : Effets indésirables des Médicaments : Incidence et Risque, sur les hospitalisations liées à un effet indésirable médicamenteux. Coordination CRPV de Bordeaux. Décembre, 2000. ,
DOI : 10.1136/bmj.320.7241.1036
URL : http://www.bmj.com/content/bmj/320/7241/1036.full.pdf
Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies, EP Europace, vol.15, issue.6, pp.787-97, 2013. ,
DOI : 10.1093/europace/eut001
Age and the Risk of Warfarin-Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation Study, Journal of the American Geriatrics Society, vol.335, issue.8, 2006. ,
DOI : 10.1212/WNL.55.7.947
Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation, Annals of Internal Medicine, vol.141, issue.10, pp.745-52, 2004. ,
DOI : 10.7326/0003-4819-141-10-200411160-00005
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice, Journal of the American Heart Association, vol.4, issue.7, 2015. ,
DOI : 10.1161/JAHA.115.001921
Risks of Oral Anticoagulant Therapy With Increasing Age, Archives of Internal Medicine, vol.165, issue.13, pp.1527-1559, 2005. ,
DOI : 10.1001/archinte.165.13.1527
Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation, pp.2689-96, 2007. ,
Letter regarding article by Hylek et alMajor hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation". Circulation, p.538, 2007. ,
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial, The Lancet, vol.370, issue.9586, pp.493-503, 2007. ,
DOI : 10.1016/S0140-6736(07)61233-1
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT), The Lancet, vol.348, issue.9025, pp.423-431, 1996. ,
DOI : 10.1016/S0140-6736(96)01109-9
Outcomes and Safety of Antithrombotic Treatment in Patients Aged 80 Years or Older With Nonvalvular Atrial Fibrillation, The American Journal of Cardiology, vol.107, issue.10, pp.1489-93, 2011. ,
DOI : 10.1016/j.amjcard.2011.01.025
Stroke and Major Bleeding Risk in Elderly Patients Aged >=75 Years With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project, Stroke, vol.46, issue.1, pp.143-50, 2015. ,
DOI : 10.1161/STROKEAHA.114.007199
Assessing bleeding risk in patients taking anticoagulants, Journal of Thrombosis and Thrombolysis, vol.9, issue.3, pp.312-321 ,
DOI : 10.1111/j.1538-7836.2011.04378.x
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888359/pdf
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment, Chest, vol.133, issue.6, pp.257-298, 2008. ,
DOI : 10.1378/chest.08-0674
Comparison of Outcomes Among Patients Randomized to Warfarin Therapy According to Anticoagulant Control, Archives of Internal Medicine, vol.167, issue.3 ,
DOI : 10.1001/archinte.167.3.239
Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression, Thrombosis Journal, vol.12, issue.1, p.2014 ,
DOI : 10.1186/1477-9560-12-14
Gender differences of bleeding and stroke risk in very Old atrial fibrillation patients on VKA treatment, Thrombosis Research, vol.131, issue.1, pp.12-18, 2013. ,
DOI : 10.1016/j.thromres.2012.10.009
Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations, Gut, vol.55, issue.12, pp.1731-1739, 2006. ,
DOI : 10.1136/gut.2005.080754
The risk of hemorrhagic complications in hospital inpatients who fall while receiving antithrombotic therapy, Thrombosis Journal, vol.3, issue.1, p.1, 2005. ,
DOI : 10.1186/1477-9560-3-1
Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients, American Heart Journal, vol.161, issue.2, pp.241-247, 2011. ,
DOI : 10.1016/j.ahj.2010.11.002
Risk of Falls and Major Bleeds in Patients on Oral Anticoagulation Therapy, The American Journal of Medicine, vol.125, issue.8, pp.773-781, 2012. ,
DOI : 10.1016/j.amjmed.2012.01.033
Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall, The American Journal of Medicine, vol.118, issue.6, pp.612-619, 2005. ,
DOI : 10.1016/j.amjmed.2005.02.022
Choosing Antithrombotic Therapy for Elderly Patients With Atrial Fibrillation Who Are at Risk for Falls, Archives of Internal Medicine, vol.159, issue.7, pp.677-85, 1999. ,
DOI : 10.1001/archinte.159.7.677
URL : http://archinte.jamanetwork.com/data/journals/intemed/11941/ioi80382.pdf
A New Risk Scheme to Predict Warfarin-Associated Hemorrhage, Journal of the American College of Cardiology, vol.58, issue.4 ,
DOI : 10.1016/j.jacc.2011.03.031
URL : https://doi.org/10.1016/j.jacc.2011.03.031
The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study, BMJ, vol.350, issue.feb03 4, p.246 ,
DOI : 10.1136/bmj.h246
Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands, British Journal of Clinical Pharmacology, vol.27, issue.1, 2011. ,
DOI : 10.1111/j.1365-2125.1992.tb04001.x
Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study, Circulation, vol.112, issue.12, pp.1687-91, 2005. ,
DOI : 10.1161/CIRCULATIONAHA.105.553438
Association Between CHADS2 Risk Factors and Anticoagulation-Related Bleeding: A Systematic Literature Review, Mayo Clinic Proceedings, vol.86, issue.6, 2011. ,
DOI : 10.4065/mcp.2010.0755
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104910/pdf
Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic, Clinical Therapeutics, vol.26, issue.9 ,
DOI : 10.1016/j.clinthera.2004.09.002
Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas, Stroke, vol.36, issue.7, pp.1588-93, 2005. ,
DOI : 10.1161/01.STR.0000170642.39876.f2
URL : http://stroke.ahajournals.org/content/strokeaha/36/7/1588.full.pdf
Risk of bleeding in very old atrial fibrillation patients on warfarin: Relationship with ageing and CHADS2 score, Thrombosis Research, vol.121, issue.3, pp.347-52, 2007. ,
DOI : 10.1016/j.thromres.2007.05.014
Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation, Stroke, vol.46, issue.8 ,
DOI : 10.1161/STROKEAHA.115.009371
Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: A secondary analysis, Clinical Therapeutics, vol.31, issue.7, pp.1534-1543, 2009. ,
DOI : 10.1016/j.clinthera.2009.07.015
Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban: The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation, Stroke, vol.45, issue.5, pp.1304-1316, 2014. ,
DOI : 10.1161/STROKEAHA.113.004506
Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF), American Heart Journal, vol.151, issue.3, pp.713-722, 2006. ,
DOI : 10.1016/j.ahj.2005.04.017
Les nouveaux anticoagulants et la fibrillation atriale du sujet âgé, Geriatr Psychol Neuropsychiatr Vieil, vol.11, 2013. ,
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation, New England Journal of Medicine, vol.365, issue.10, pp.883-91, 2011. ,
DOI : 10.1056/NEJMoa1009638
URL : https://hal.archives-ouvertes.fr/hal-01038111
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. Cochrane Database Syst Rev, p.8980, 2013. ,
Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis, Heart, vol.369, issue.15, pp.1204-1215, 2015. ,
DOI : 10.1056/NEJMoa1302507
Systematic review with meta-analysis: the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants, Alimentary Pharmacology & Therapeutics, vol.350, issue.11-12, pp.11-121239, 2015. ,
DOI : 10.1136/bmj.h1857
Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis, American Journal of Cardiovascular Drugs, vol.177, issue.6, pp.259-65, 2015. ,
DOI : 10.1016/j.ijcard.2014.09.099
Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD, Journal of the American Society of Nephrology, vol.25, issue.3, pp.431-473, 2014. ,
DOI : 10.1681/ASN.2013040361
Evaluation of Trends of Inpatient Hospitalisation for Significant Haemorrhage in Patients Anticoagulated for Atrial Fibrillation before and after the Release of Novel Anticoagulants, Heart, Lung and Circulation, vol.24, issue.1, pp.94-101 ,
DOI : 10.1016/j.hlc.2014.06.013
New Oral Anticoagulants in Elderly Adults: Evidence from a Meta-Analysis of Randomized Trials, Journal of the American Geriatrics Society, vol.3, issue.Suppl 10, p.2014 ,
DOI : 10.1136/bmjopen-2013-002758
Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation. Circulation, pp.157-64, 2015. ,
du bénéfice/risque à court terme des nouveaux anticoagulants oraux (dabigatran, rivaroxaban) chez les patients débutant un traitement et non précédemment traités par des antivitamine K, 2016. ,
Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study ,
Oral Anticoagulation and Hemorrhagic Complications in an Elderly Population With Atrial Fibrillation, Archives of Internal Medicine, vol.161, issue.17, pp.2125-2133, 2001. ,
DOI : 10.1001/archinte.161.17.2125
URL : http://archinte.jamanetwork.com/data/journals/intemed/11991/ioi00745.pdf
People Aged Over 75 in Atrial Fibrillation on Warfarin: The Rate of Major Hemorrhage and Stroke in More Than 500 Patient-Years of Follow-Up, Journal of the American Geriatrics Society, vol.128, issue.4, pp.655-664, 2005. ,
DOI : 10.7326/0003-4819-128-5-199803010-00012